Phase Ⅱ Study of Fully Human BCMA-Targeting CAR-T Cells (Zevorcabtagene Autoleucel) in Patients with Relapsed/Refractory Multiple Myeloma

Author:

Chen Wenming1,Fu Chengcheng2,Fang Baijun3,Liang Aibin4,Xia Zhongjun5,He Yanjuan6,Lu Jin7,Liu Hui8,Hou Ming9,Cai Zhen10,Yang Wei11,Hao Siguo12,Jiang Songfu13,Jing Hongmei14,Liu Jing15,Du Xin16,Fu Rong17,Mei Heng18,Zhu Zunmin19,Yang Yanli20,Liu Hong21,Yuan Daijing22,Zhao Hongxia22,Xiao Jun22,Wang Wei22,Wang Huamao22,LI Zonghai22

Affiliation:

1. 1Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China

2. 2MD, PhD, The First Affilliated Hospital of Soochow University, Suzhou, CHN

3. 3Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University and the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

4. 4School of Medicine, Tongji Hospital of Tongji University, Shanghai, China

5. 5Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China

6. 6Department of Hematology, Xiangya Hospital; Central South University, changsha, China

7. 7Institute of Hematology of Peking University, Beijing, China

8. 8Department of Hematology, Beijing Hospital, Beijing, China

9. 9Department of Hematology, Qilu Hospital of Shandong University, Jinan, China

10. 10Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China

11. 11Shengjing Hospital of China Medical University, Shenyang, China

12. 12Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China

13. 13The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

14. 14Department of Hematology, Peking University Third Hospital, Beijing, China

15. 15Department of Hematology, The Third Xiangya Hospital of Central South University, Changsha, China

16. 16Division of Hematology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China

17. 17Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China

18. 18Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

19. 19Department of Hematology, Henan Provincial People's Hospital, Zhengzhou, China

20. 20The First Affiliated Hospital of Bengbu Medical Collegue, Bengbu, China

21. 21Affiliated Hospital of Nantong University, Nantong, CHN

22. 22CARsgen Therapeutics Co. Ltd, Shanghai, China

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3